Cardiovascular Research Advance Access first published online on July 25, 2009
This version [Corrected Proof] published online on August 13, 2009
Cardiovascular Research, doi:10.1093/cvr/cvp263
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1
1 Cell signaling and Bioimaging Laboratory, Department of Bio and Brain Engineering, KAIST, 335 Gwahangno, Yuseong-gu, Daejeon 305-701, Korea
2 Department of Life Science and Center for Cell Signaling and Drug Discovery Research, Ewha Womans University, Seoul 127-750, Korea
* Corresponding author. Tel: +82 42 350 4321, Fax: +82 42 350 4380, Email: cchoi{at}kaist.ac.kr
Aims: A reduction in the level of thioredoxin 1 (Trx1) has been proposed as a possible mechanism for the tumor-specific growth arrest caused by inhibition of histone deacetylases (HDACs). In this study, we investigated the effect of trichostatin A (TSA), a potent HDAC inhibitor, on the proliferation and migration of vascular smooth muscle cells (VSMCs), and we examined the role of reduced Trx1 levels in this effect.
Methods and results: TSA treatment time-dependently decreased Trx1 expression in rat VSMCs at both the mRNA and protein levels. It also enhanced platelet-derived growth factor (PDGF)-induced proliferation and migration of the VSMCs. By potentiating Akt phosphorylation, the siRNA-induced downregulation of Trx1 also enhanced VSMC proliferation and migration in response to PDGF or serum treatment. Consistent with these results, TSA administration increased neointimal thickening in a murine model of post-angioplastic restenosis.
Conclusion: These data demonstrate that TSA enhances vascular proliferative activity by downregulating Trx1, thus activating an Akt-dependent pathway. Our results indicate that, in addition to its apoptotic effects in tumour cells, the downregulation of Trx1 has a proliferative role in primary VSMCs.
KEYWORDS Histone deacetylases; Thioredoxin; Vascular smooth muscle cells; Proliferation; Migration
Time for primary reveiw: 16 days